PENTAFLUOROSULFANYL-BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF AND ITS UTILIZATION AS MEDICAMENT OR DIAGNOSTIC AGENT AND MEDICAMENT CONTAINING SAME

(EN) The invention relates to pentafluorosulfanyl-benzoylguanidines of formula (I) and (II), wherein R1 to R4 have the meaning mentioned in the claims. Said pentafluorosulfanyl-benzoylguanidines are suitable as antiarrhythmic medicaments with cardioprotective components for the prophylaxis or treatment of infarction and for the treatment of angina pectoris. They also preventively inhibit pathophysiological processes during the occurrence of ischaemically induced injuries, more particularly the triggering of ischaemically induced cardiac arrhythmia

Bruningstraße 50, 65929 Frankfurt Germany

AVENTIS PHARMA DEUTSCHLAND GMBH

2591/CHENP/2004 A

2591/CHENP/2004

INDIA

2009-03-20T11:22:19Z

2007-03-02

2004-11-18

317918

2003-05-05

PCT/EP2003/04669

C07C 381/00

WO 2003/097591

KLEEMANN, Heinz-Werner

3468

308

Germany

2002-05-18

102 22 192.8

2007-03-02

PENTAFLUOROSULFANYL-BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF AND ITS UTILIZATION AS MEDICAMENT OR DIAGNOSTIC AGENT AND MEDICAMENT CONTAINING SAME 36z20IzP

2009-04-30T18:40:37Z

56251 KLEEMANN, HEINZ-WERNER 26156 AVENTIS PHARMA DEUTSCHLAND